Difference between revisions of "Alvarez Diego F"
From Bioblast
Beno Marija (talk | contribs) |
Tindle Lisa (talk | contribs) |
||
Line 16: | Line 16: | ||
== Participated at == | == Participated at == | ||
::::* [[MiPNet27.02 IOC153 Innsbruck AT]] | ::::* [[MiPNet27.02 IOC153 Innsbruck AT]] | ||
::::* [[Bioblast 2022|Bioblast 2022: BEC Inaugural Conference]] |
Latest revision as of 10:44, 6 July 2022
Name | Alvarez Diego F, MD, PhD |
---|---|
Institution | Department of Physiology & Pharmacology Sam Houston State University College of Osteopathic Medicine Texas, US |
Address | 925 City Central Avenue, TX 77304 |
City | Conroe |
State/Province | Texas (TX) |
Country | USA |
diego.alvarez@shsu.edu | |
Weblink | ORCID ID |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Audia 2018 Basic Res Cardiol | 2018 | Audia JP, Yang XM, Crockett ES, Housley N, Haq EU, O'Donnell K, Cohen MV, Downey JM, Alvarez DF (2018) Caspase‑1 inhibition by VX‑765 administered at reperfusion in P2Y12 receptor antagonist‑treated rats provides long‑term reduction in myocardial infarct size and preservation of ventricular function. Basic Res Cardiol 113:32. |
Yuzefovych 2013 Endocrinology | 2013 | Yuzefovych LV, Schuler AM, Chen J, Alvarez DF, Eide L, Ledoux SP, Wilson GL, Rachek LI (2013) Alteration of mitochondrial function and insulin sensitivity in primary mouse skeletal muscle cells isolated from transgenic and knockout mice: role of OGG1. Endocrinology 154:2640-9. |
Abstracts
Published | Reference | |
---|---|---|
Alvarez 2022 Bioblast2022 | 2022 | Participant: Bioblast 2022 and NextGen-O2k Workshop. |